Journal Information
Vol. 92. Issue 4.
Pages 409-413 (July - August 2016)
Visits
2480
Vol. 92. Issue 4.
Pages 409-413 (July - August 2016)
Original article
Open Access
Evaluation of a neonatal screening program for sickle-cell disease
Avaliação de um programa de triagem neonatal para doença falciforme
Visits
2480
Rodrigo Ellera,
Corresponding author
rodrigoellersrl@gmail.com

Corresponding author.
, Denise Bousfield da Silvab
a Medical School, Universidade Federal de Santa Catarina (UFSC), Florianópolis, SC, Brazil
b Department of Pediatrics, Universidade Federal de Santa Catarina (UFSC), Florianópolis, SC, Brazil
This item has received

Under a Creative Commons license
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (3)
Table 1. Number of live births, screened children, and percentage of coverage of the Neonatal Screening Program of the Health Secretariat of the State of Santa Catarina, from January 2003 to December 2012.
Table 2. Number of children with sickle-cell trait and disease diagnosed by the Neonatal Screening Program of the Health Secretariat of the State of Santa Catarina, from January 2003 to December 2012.
Table 3. Distribution of sickle-cell disease per health macro-region of the State of Santa Catarina, from January 2003 to December 2012.
Show moreShow less
Abstract
Objective

Evaluate the Neonatal Screening Program of the Health Secretariat of the State of Santa Catarina for sickle-cell disease, from January 2003 to December 2012, regarding program coverage and disease frequency.

Methods

Descriptive, observational, cross-sectional study with retrospective data collection. The variables analyzed were: number of live births in the State of Santa Catarina; number of screened children; number of children diagnosed with sickle-cell trait and sickle-cell disease; type of sickle-cell disease diagnosed; age at the time of sample collection, ethnicity/skin color, gender, and origin of children with sickle-cell disease. Descriptive measures and frequency tables were used for data analysis.

Results

During the study period, there were 848,833 live births and 730,412 samples were screened by the program, resulting in a coverage of 86.0%. There were 6173 samples positive for sickle-cell trait and 39 for sickle-cell disease. Among children with sickle-cell disease, the median age at the time of sample collection was 6 days. Regarding the ethnicity/skin color, 25 (64.1%) children were white, seven were black, and seven others were not specified. The Midwest and the Highland (Planalto Serrano) of Santa Catarina were the regions with the highest incidence of sickle-cell disease.

Conclusion

Coverage by the Neonatal Screening Program of Santa Catarina is good, but did not demonstrate an improvement trend over the years. The frequency of sickle-cell disease is low and lower than in the North, Northeast, and Midwest regions. The median age in days at the time of collection is older than the age recommended by the Ministry of Health.

Keywords:
Sickle cell disease
Neonatal screening
Santa Catarina State
Resumo
Objetivo

avaliar o Programa de Triagem Neonatal da Secretaria de Saúde do Estado de Santa Catarina (PTN-SES/SC) para doença falciforme no período de janeiro de 2003 a dezembro de 2012, em relação à sua cobertura e à frequência da doença.

Métodos

estudo descritivo, observacional e transversal com coleta retrospectiva dos dados. As variáveis analisadas foram: número de nascidos-vivos no Estado de Santa Catarina; número de crianças triadas; número de crianças diagnosticadas com traço e doença falciforme (DF); tipo de DF diagnosticada; idade da coleta, cor/raça, sexo e procedência das crianças com DF. Foram utilizadas as medidas descritivas e as tabelas de frequência para análise dos dados.

Resultados

no período estudado, houve 848.833 nascidos-vivos e 730.412 amostras triadas pelo programa, gerando cobertura de 86,0%. Das amostras triadas, foram encontradas 6.173 crianças com traço falciforme e 39 com DF. Entre as crianças com DF, a mediana da idade em dias na data da coleta foi de 6. Das 39 crianças doentes, 25 (64,1%) eram da cor/raça branca, 7da negra e 7 de outra cor/raça. As regiões do planalto serrano e do meio-oeste de Santa Catarina foram as regiões com maior incidência de DF.

Conclusões

a cobertura do PTN-SES/SC é boa, contudo não apresentou tendência de melhora ao longo dos anos. A frequência da DF é baixa e menor que nas regiões Norte, Nordeste e Centro-oeste. A mediana da idade em dias no momento da coleta está acima do preconizado pelo Ministério da Saúde.

Palavras-chave:
Doença falciforme
Triagem neonatal
Estado de Santa Catarina
Full Text
Introduction

Sickle-cell disease (SCD) represents a group of autosomal-recessive inherited hematological diseases, which includes several genotypes, with a prevalence of hemoglobin S (HbS).1–3 The presence of this abnormal hemoglobin is responsible for the main clinical manifestations of the disease, which originate from vaso-occlusive phenomena and chronic ischemic disorders.4

The distribution of SCD is a heterogeneous one and is more common among those of African ascendancy. According to 2009 data from the Brazilian Institute of Geography and Statistics (Instituto Brasileiro de Geografia e Estatística – IBGE), in Brazil, black and brown individuals represented 6.9% and 44.2% of the population, respectively, reflecting the heterogeneity of SCD in the country.5

In June 2001, through Ministry of Health Decree No. 822, several diseases were added to the list of those screened through the existing National Neonatal Screening Program (NSP) (phenylketonuria and congenital hypothyroidism), to include the detection of SCD and other hemoglobinopathies, as well as cystic fibrosis.6 The diagnosis of SCD is performed by a laboratory through the detection of HbS and its association with quantitative fractions of other hemoglobins.

The NSP, together with multidisciplinary care, has allowed a significantly reduction in morbidity and mortality from the disease, as shown by studies in other countries.6

The aim of this study was to evaluate the NSP of the Health Secretariat of the State of Santa Catarina (Programa de Triagem Neonatal da Secretaria da Saúde do Estado de Santa Catarina [NSP-SES/SC]) for SCD and other hemoglobinopathies in relation to their coverage and the incidence of SCD and sickle-cell trait from January 2003 to December 2012.

Methods

This was a descriptive, observational, cross-sectional study approved by the Ethics Committee of Hospital Infantil Joana de Gusmão under opinion No. 029/2013.

The assessed variables were obtained retrospectively from a database at the Central Laboratory (Laboratório Central [LACEN]) of the Health Secretariat of the State of Santa Catarina (Secretaria da Saúde do Estado de Santa Catarina [SES/SC]) and the Live Birth Information System (Sistema de Informações sobre Nascidos Vivos [SINASC]). The collected data comprise the period from January 2003 to December 2012.

The variables included: number of live births in the State of Santa Catarina; number of children screened by the NSP-SES/SC for SCD and other hemoglobinopathies; number of children diagnosed with SCD and sickle-cell trait by the NSP-SES/SC; type of SCD diagnosed by the aforementioned program; final diagnosis of children whose first samples were inconclusive; age at collection, ethnicity/skin color, gender, and origin of children with SCD according to the macro-regions of Santa Catarina.7

Regarding the variable ethnicity/skin color, it used the criterion established by the Brazilian Institute of Geography and Statistics (Instituto Brasileiro de Geografia e Estatística [IBGE]).5 The information on this variable was obtained from the file completed by the nursing staff at the time of blood sample collection.

Blood sample collection was carried out by the nursing staff in hospitals, maternity hospitals, or basic health units in the municipalities of Santa Catarina. The sample, taken from the child's heel and deposited on filter paper discs, was later sent to LACEN for analysis.

The method used to test blood samples was high-performance liquid chromatography associated with the cation-exchange chromatography, using the Variant II device (Bio-Rad®, CA, USA).

Samples with results different from the Hb FA pattern were submitted to another distinct chromatography test. The isoelectric focusing test was usually used for this assessment. When the results of both tests were distinct, constituting an inconclusive result, the child was called for a new sample collection.

Children whose samples had an indeterminate result, i.e., a hemoglobin type different from the hemoglobin that can be identified by standard screening tests, were referred for diagnostic clarification at Hospital Infantil Joana de Gusmão (HIJG), a referral center in the State of Santa Catarina for neonatal screening tests.

Descriptive measures and frequency tables were used for analysis of the results.

Results

From January 2003 to December 2012, 730,412 samples were submitted to screening test of the NSP-SES/SC. During this period, 848,833 children were born in the state, according to SINASC, which indicates a program coverage of 86.0% (Table 1).

Table 1.

Number of live births, screened children, and percentage of coverage of the Neonatal Screening Program of the Health Secretariat of the State of Santa Catarina, from January 2003 to December 2012.

Year  Live birthsa  Screened childrenb  Coverage 
2003  83,177  67,993  81.7% 
2004  85,475  80,243  93.9% 
2005  84,584  80,333  95.8% 
2006  84,133  68,063  80.9% 
2007  81,903  69,925  85.4% 
2008  85,262  80,172  94.0% 
2009  83,489  73,437  88.0% 
2010  84,611  61,997  73.3% 
2011  87,481  78,127  89.3% 
2012  88,772  70,122  78.0% 
Total  848,833  730,412  86.0% 

No justifications were found for the low coverage in 2010.

a

Live Birth Information System (Sistema de Informações sobre Nascidos Vivos [SINASC]).7

b

Central Laboratory (Laboratório Central [LACEN]) of the Health Secretariat of the State of Santa Catarina.

SCD was identified in 39 children of the screened samples. Of these, 26 cases showed the FS pattern (in order of decreasing quantity, presence of hemoglobins F and S, in the absence of hemoglobin A); 12 FSC (presence of hemoglobins F, S and C, in the absence of hemoglobin A); and one FSA (presence of hemoglobins F, S and A; Table 2). Each of these samples was submitted to two tests – high-performance liquid chromatography and isoelectric focusing – with equivalent results. Whether there was further confirmation of the results with other diagnostic tests was not assessed.

Table 2.

Number of children with sickle-cell trait and disease diagnosed by the Neonatal Screening Program of the Health Secretariat of the State of Santa Catarina, from January 2003 to December 2012.

Year  FAS pattern  FS pattern  FSC pattern  FSA pattern 
2003  491 
2004  666 
2005  655 
2006  550 
2007  607 
2008  692 
2009  659 
2010  509 
2011  683 
2012  661 
Total  6173  26  12 

Source: Central Laboratory (Laboratório Central [LACEN]) of the Health Secretariat of the State of Santa Catarina.

The result was indeterminate in 302 samples, i.e., the hemoglobin was different from hemoglobins that can be diagnosed by neonatal screening methods. These children were referred to the HIJG for diagnostic clarification.

Of the samples analyzed by the NSP-SES/SC, 41 showed inconclusive results and 25 children with these results did not undergo a second test, despite the program's recommendation. Of the remaining 16 children that had a new sample collected, six once again showed an inconclusive pattern, seven showed a normal pattern, and three had sickle-cell trait pattern. Thus, 31 children with an inconclusive pattern did not have a definite diagnosis (Fig. 1).

Figure 1.

Number of live births, screened samples, and respective diagnoses at the NSP-SES/SC, from January 2003 to December 2012.

(0.14MB).

Regarding the origin, the Midwest and Highland macro-regions had the highest percentages of SCD cases (Table 3).

Table 3.

Distribution of sickle-cell disease per health macro-region of the State of Santa Catarina, from January 2003 to December 2012.

Health macro-region  Number of cases of sickle cell diseasea  Number of live births per region  Incidence per region 
Great-West  97,705 
Midwest  86,921  1:10,865 
North highlands  56,624  1:56,624 
Northeast  122,663  1:15,333 
Itajaí Valley  120,420  1:120,420 
Itajaí river estuary  76,502  1:15,300 
Highland  42,259  1:10,565 
Greater Florianópolis  10  129,362  1:12,932 
South  116,427  1:58,213 
Total  39  848,883  1:18,728 

Source: Live Birth Information System (Sistema de Informações sobre Nascidos Vivos [SINASC])7 and Central Laboratory (Laboratório Central [LACEN]) of the Health Secretariat of the State of Santa Catarina.

a

Sickle-cell disease (FS, FSC, and FSA).

Regarding the skin color/ethnicity of children with SCD (patterns FS, FSC, and FSA), 25 (64.1%) were white; seven were black, and seven were of ethnicity/skin color not specified in the sample collection form. As for gender, 24 were males and 15 were females. The mean age on the sample collection day was 9.08 days and the median was 6 days.

Discussion

The main result of this study was to confirm the frequency of SCD (1:18,728) and sickle-cell trait (1:118) in the State of Santa Catarina, as well as the coverage of the neonatal screening program in the state (86.0%).

The incidence of SCD was low, possibly due to the small proportion of African descendants in the State of Santa Catarina. Blacks, according to IBGE, accounted for only 2.2%, and mixed-race, 11.7% of the state population in the year 2009.5 The highest SCD incidence occurred in the Midwest and Highland macro-regions of Santa Catarina.

In Brazil, in 2003, the incidence of SCD was 1:650 in Bahia, the state with the highest proportion of blacks in the population,8 while in Rio de Janeiro it was 1:1288 in 2007.9 However, a study carried in 2004 in Rio Grande do Sul showed an incidence of SCD of 1:39,100,10 and another performed in Paraná between 2002 and 2004 showed an incidence of 1:20,320.11

The observed coverage may not reflect the actual screening coverage of all live births. Even though all the municipalities in the state have joined this program, some children may have been screened in the private health care network, which does not generate record for the NSP-SES/SC and reflects a failure of the state's monitoring program.

In studies conducted in Brazil, it was observed that the program coverage in the Federal District was 83.4% in 200612; in Bahia, 88.9% between the years 2007 and 200913; and in Mato Grosso do Sul, 91.8% between 2006 and 2010.14 The goal of 100% coverage of the neonatal screening programs is still a challenge, even in more developed countries.9 Canada and Belgium, in 2006, achieved coverage of 76%15 and 87%,16 respectively.

Among the children with SCD in the period analyzed in this study, the mean age on sample collection day was 8.58 days and the median was 6 days, showing the need to improve these variables, as the Ministry of Health recommends that the collection be performed between 3 and 5 days of life. Although the test can be performed later, it is of utmost importance to collect the sample within the ideal period for some of the screened diseases, in order to provide early diagnosis and treatment, as well as to benefit from the prevention of sequelae.

A higher number of white patients was observed (64.1%) among the 39 SCD cases. The higher incidence of the disease in whites can be explained by the higher number of these individuals among the State of Santa Catarina's population, which, according to 2009 IBGE data, accounted for 85.7% of the total population,5 in addition to the white ethnicity being misattributed to the mixed-race population. The data limitation regarding skin color/ethnicity originates from the fact that this information is filled out by the person who completed the blood sample form and not based on a detailed family background questionnaire, considering the interpretative disagreement between skin color and ethnicity of a particular individual. It is essential, however, to be aware that none of these limitations affect the major aspects assessed in this study.

Regarding children with inconclusive and indeterminate results, it is important to create mechanisms to intensify the search for these individuals, aiming to expand the program's scope and to identify and provide early treatment to any SCD carriers – which in this study was of a low frequency, considering the number of screened samples.

One limitation of this study is due to lack of patient monitoring after diagnosis through the neonatal screening, in order to assess patient adherence to the interdisciplinary outpatient follow-up and health measures proposed by the program. Recently, a study performed in Minas Gerais found that neonatal screening in that state, even if carried out in a comprehensive and effective manner, was not enough to reduce SCD mortality, which was 7.4% in the first 14 years, with slightly more than half of the deaths occurring before 2 years of age.17

The drastic reduction in mortality related to SCD in the early years of life, from 26% to 1–2%, occurred due to comprehensive care provided to this population at pediatric referral centers. Therefore, early diagnosis and treatment of SCD helps to increase survival and significantly improves the quality of life of these individuals.6,18

Thus, it can be concluded that the NSP has good coverage in Santa Catarina and that the incidence of SCD in the state is quite low. Nevertheless, it is essential to assess patients’ adherence to health measures recommended by the NSP, as without this follow-up, the diagnosis alone becomes pointless. With the information provided by this study, the authors intend to seek the affected children and assess adherence to outpatient medical follow-up, as well as the health support offered to patients, in order to actually evaluate the program's efficacy.

Conflicts of interest

The authors declare no conflicts of interest.

References
[1]
C.L. Lobo, S.K. Ballas, A.C. Domingos, P.G. Moura, E.M. do Nascimento, G.P. Cardoso, et al.
Newborn screening program for hemoglobinopathies in Rio de Janeiro, Brazil.
Pediatr Blood Cancer, 61 (2014), pp. 34-39
[2]
D. Campos Júnior, D.A. Burns, F.A. Lopez.
Tratado de pediatria: Sociedade Brasileira de Pediatria.
3rd ed., Manole, (2014),
[3]
R.M. Kliegman.
Nelson tratado de pediatria.
14th ed., Elsevier, (2014),
[4]
L. Goldman, D. Ausiello.
Cecil medicina.
23rd ed., Elsevier, (2009),
[5]
Instituto Brasileiro de Geografia e Estatística. Síntese de indicadores sociais: uma análise das condições de vida da população brasileira 2010. Available from: http://biblioteca.ibge.gov.br/visualizacao/livros/liv45700.pdf [cited 01.09.14].
[6]
K.L. Hassel.
Population estimates of sickle cell disease in the U.S..
Am J Prev Med, 38 (2010), pp. S512-S521
[7]
Tabnet. Departamento de Informática do Sistema Único de Saúde (DATASUS). Available from: http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sinasc/cnv/nvsc.def [cited 01.09.14].
[8]
A. Almeida, T.M. Godinho, M.S. Teles, A.P.P. Rehem, H.M. Jalil, T.G. Fukuda, et al.
Avaliação do programa de triagem neonatal na Bahia no ano de 2003.
Rev Bras Saúde Matern Infant, 6 (2006), pp. 85-91
[9]
J. Botler, L.A. Camacho, M.M. Cruz.
Phenylketonuria, congenital hypothyroidism and haemoglobinopathies: public health issues for a Brazilian newborn screening program.
Cad Saude Publica, 28 (2012), pp. 1623-1631
[10]
C.K. Sommer, A.S. Goldbeck, S.C. Wagner, S.M. Castro.
Triagem neonatal para hemoglobinopatias: experiência de um ano na rede pública do Rio Grande do Sul, Brasil.
Cad Saude Publica, 22 (2006), pp. 1709-1714
[11]
A.M. Watanabe, M.A. Pianovski, J. Zanis Neto, L.C. Lichtvan, E.A. Chautard-Freire-Maia, M.T. Domingos, et al.
Prevalência da hemoglobina S no estado do Paraná, Brasil, obtida pela triagem neonatal.
Cad Saude Publica, 24 (2008), pp. 993-1000
[12]
D. Diniz, C. Guedes, L. Barbosa, P.L. Tauil, I. Magalhães.
Prevalência do traço falciforme e da anemia falciforme em recém-nascidos do Distrito Federal, Brasil, 2004 a 2006.
Cad Saude Publica, 25 (2009), pp. 188-194
[13]
T. Amorim, H. Pimentel, M.I.M.M. Fontes, A. Purificação, P. Lessa.
Avaliação do Programa de Triagem Neonatal na Bahia entre 2007 e 2009 – As lições da doença falciforme.
Gaz Med Bahia, 80 (2010), pp. 10-13
[14]
M.L. Ivo, O.M. Araujo, A.R. Barbieri, R.A. Corrêa Filho, E.R. Pontes, C.A. de Oliveira Botelho.
Scope and efficiency of the newborn screening program in identifying hemoglobina S.
Rev Bras Hematol Hemoter, 36 (2014), pp. 14-18
[15]
B.L. Therrell, J. Adams.
Newborn screening in North America.
J Inherit Metab Dis, 30 (2007), pp. 447-465
[16]
G. Loeber.
Neonatal screening in Europe: the situation in 2004.
J Inherit Metab Dis, 30 (2007), pp. 430-438
[17]
A.P. Sabarense, G.O. Lima, L.M. Silva, M.B. Viana.
Characterization of mortality in children with sickle cell disease diagnosed through the Newborn Screening Program.
J Pediatr (Rio J), 91 (2015), pp. 242-247
[18]
C.T. Quinn, Z.R. Rogers, T.L. McCavit, G.R. Buchanan.
Improved survival of children and adolescents with sickle cell disease.
Blood, 115 (2010), pp. 3447-3452

Please cite this article as: Eller R, Silva DB. Evaluation of a neonatal screening program for sickle-cell disease. J Pediatr (Rio J). 2016;92:409–13.

Article associated to Hospital Infantil Joana de Gusmão, Florianópolis, SC, Brazil.

Copyright © 2016. Sociedade Brasileira de Pediatria
Idiomas
Jornal de Pediatria (English Edition)
Article options
Tools
en pt
Taxa de publicaçao Publication fee
Os artigos submetidos a partir de 1º de setembro de 2018, que forem aceitos para publicação no Jornal de Pediatria, estarão sujeitos a uma taxa para que tenham sua publicação garantida. O artigo aceito somente será publicado após a comprovação do pagamento da taxa de publicação. Ao submeterem o manuscrito a este jornal, os autores concordam com esses termos. A submissão dos manuscritos continua gratuita. Para mais informações, contate assessoria@jped.com.br. Articles submitted as of September 1, 2018, which are accepted for publication in the Jornal de Pediatria, will be subject to a fee to have their publication guaranteed. The accepted article will only be published after proof of the publication fee payment. By submitting the manuscript to this journal, the authors agree to these terms. Manuscript submission remains free of charge. For more information, contact assessoria@jped.com.br.
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.